A preliminary study of individual cognitive behavior therapy for social anxiety disorder in Japanese clinical settings: A single-arm, uncontrolled trial

BMC Research Notes

Volumn 6, Issue 1, 2013, Pages

  Yoshinaga, Naoki ^a,b   Ohshima, Fumiyo ^a,b   Matsuki, Satoshi ^a,b   Tanaka, Mari ^a   Kobayashi, Tomomi ^a   Ibuki, Hanae ^a   Asano, Kenichi ^b   Kobori, Osamu ^a,b   Shiraishi, Tetsuya ^a,b   Ito, Emi ^b   Nakazato, Michiko ^b   Nakagawa, Akiko ^b   Iyo, Masaomi ^a   Shimizu, Eiji ^a,b  

^a CHIBA UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

CBT; Cognitive behavioral therapy; Japanese; SAD; Social anxiety disorder; Social phobia

Indexed keywords

ADULT; ANXIETY DISORDER; ARTICLE; CLINICAL TRIAL; COGNITIVE THERAPY; FEASIBILITY STUDY; FEMALE; HUMAN; JAPAN; MALE; TREATMENT OUTCOME;

ADULT; ANXIETY DISORDERS; COGNITIVE THERAPY; FEASIBILITY STUDIES; FEMALE; HUMANS; JAPAN; MALE; TREATMENT OUTCOME; YOUNG ADULT;

MLCS; MLOWN;

EID: 84874391698     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-6-74     Document Type: Article

References (55)

1. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition: DSM-IV-TR Washington: American Psychiatric Pub 2000
2. Subtyping social anxiety disorder in developed and developing countries. Stein DJ, Ruscio AM, Lee S, Petukhova M, Alonso J, Andrade LHSG, Benjet C, Bromet E, Demyttenaere K, Florescu S, de Girolamo G, de Graaf R, Gureje O, He Y, Hinkov H, Hu C, Iwata N, Karam EG, Lepine J-P, Matschinger H, Oakley Browne M, Posada-Villa J, Sagar R, Williams DR, Kessler RC, Depress Anxiety 2010 27 390 403 10.1002/da.20639 20037919
3. Functional impact and health utility of anxiety disorders in primary care outpatients. Stein MB, Roy-Byrne PP, Craske MG, Bystritsky A, Sullivan G, Pyne JM, Katon W, Sherbourne CD, Med Care 2005 43 1164 1170 10.1097/01.mlr. 0000185750.18119.fd 16299426
4. Twelve-month use of mental health services in the United States: results from the National Comorbidity Survey Replication. Wang PS, Lane M, Olfson M, Pincus HA, Wells KB, Kessler RC, Arch Gen Psychiatry 2005 62 629 640 10.1001/archpsyc.62.6.629 15939840
5. Disability and poor quality of life associated with comorbid anxiety disorders and physical conditions. Sareen J, Jacobi F, Cox BJ, Belik S-L, Clara I, Stein MB, Arch Intern Med 2006 166 2109 2116 10.1001/archinte.166.19.2109 17060541
6. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders-first revision. Bandelow B, Zohar J, Hollander E, Kasper S, Möller H-J, Zohar J, Hollander E, Kasper S, Möller H-J, Bandelow B, Allgulander C, Ayuso-Gutierrez J, Baldwin DS, Buenvicius R, Cassano G, Fineberg N, Gabriels L, Hindmarch I, Kaiya H, Klein DF, Lader M, Lecrubier Y, Lépine J-P, Liebowitz MR, Lopez-Ibor JJ, Marazziti D, Miguel EC, Oh KS, Preter M, Rupprecht R, World J Biol Psychiatry 2008 9 248 312 10.1080/15622970802465807 18949648
7. A 2010 evidence-based algorithm for the pharmacotherapy of social anxiety disorder. Stein DJ, Baldwin DS, Bandelow B, Blanco C, Fontenelle LF, Lee S, Matsunaga H, Osser D, Stein MB, van Ameringen M, Curr Psychiatry Rep 2010 12 471 477 10.1007/s11920-010-0140-8 20686872
8. The evidence-based pharmacotherapy of social anxiety disorder. Blanco C, Bragdon LB, Schneier FR, Liebowitz MR, Int J Neuropsychopharmacol 2013 16 235 249 10.1017/S1461145712000119 22436306
9. Cognitive-behavioral therapy for adult anxiety disorders: a meta-analysis of randomized placebo-controlled trials. Hofmann SG, Smits JAJ, J Clin Psychiatry 2008 69 621 632 10.4088/JCP.v69n0415 18363421
10. Randomised controlled general practice trial of sertraline, exposure therapy and combined treatment in generalised social phobia. Blomhoff S, Haug TT, Hellström K, Holme I, Humble M, Madsbu HP, Wold JE, Br J Psychiatry 2001 179 23 30 10.1192/bjp.179.1.23 11435264
11. Fluoxetine, comprehensive cognitive behavioral therapy, and placebo in generalized social phobia. Davidson JRT, Foa EB, Huppert JD, Keefe FJ, Franklin ME, Compton JS, Zhao N, Connor KM, Lynch TR, Gadde KM, Arch Gen Psychiatry 2004 61 1005 1013 10.1001/archpsyc.61.10.1005 15466674
12. Cognitive-behavioral and pharmacological treatments of social phobia. A controlled study. Gelernter CS, Uhde TW, Cimbolic P, Arnkoff DB, Vittone BJ, Tancer ME, Bartko JJ, Arch Gen Psychiatry 1991 48 938 945 10.1001/archpsyc.1991. 01810340070009 1929764
13. Cognitive behavioral group therapy vs phenelzine therapy for social phobia: 12-week outcome. Heimberg RG, Liebowitz MR, Hope DA, Schneier FR, Holt CS, Welkowitz LA, Juster HR, Campeas R, Bruch MA, Cloitre M, Fallon B, Klein DF, Arch Gen Psychiatry 1998 55 1133 1141 10.1001/archpsyc.55.12.1133 9862558
14. Pretreatment attrition in a comparative treatment outcome study on panic disorder. Hofmann SG, Barlow DH, Papp LA, Detweiler MF, Ray SE, Shear MK, Woods SW, Gorman JM, Am J Psychiatry 1998 155 43 47 9433337
15. Controlled-release paroxetine in the treatment of patients with social anxiety disorder. Lepola U, Bergtholdt B, Lambert B St, Davy KL, Ruggiero L, J Clin Psychiatry 2004 65 222 229 10.4088/JCP.v65n0213 15003077
16. Venlafaxine extended release vs placebo and paroxetine in social anxiety disorder. Liebowitz MR, Gelenberg AJ, Munjack D, Arch Gen Psychiatry 2005 62 190 198 10.1001/archpsyc.62.2.190 15699296
17. Current status of research on cognitive therapy/cognitive behavior therapy in Japan. Ono Y, Furukawa TA, Shimizu E, Okamoto Y, Nakagawa A, Fujisawa D, Nakagawa A, Ishii T, Nakajima S, Psychiatry Clin Neurosci 2011 65 121 129 10.1111/j.1440-1819.2010.02182.x 21414087
18. Culture-bound syndromes and international disease classifications. Prince R, Tcheng-Laroche F, Cult Med Psychiatry 1987 11 3 52 10.1007/BF00055003 3829693
19. Anxiety disorders in Japan: a review of the Japanese literature on shinkeishitsu and taijinkyofusho. Russell JG, Cult Med Psychiatry 1989 13 391 403 10.1007/BF00052047 2612189
20. Cultural factors in social anxiety: a comparison of social phobia symptoms and Taijin kyofusho. Kleinknecht RA, Dinnel DL, Kleinknecht EE, Hiruma N, Harada N, J Anxiety Disord 1997 11 157 177 10.1016/S0887-6185(97)00004-2 9168340
21. Is taijin kyofusho a culture-bound syndrome? Suzuki K, Takei N, Kawai M, Minabe Y, Mori N, Am J Psychiatry 2003 160 1358 10.1176/appi.ajp.160.7.1358 12832264
22. Features of the offensive subtype of Taijin-Kyofu-Sho in US and Korean patients with DSM-IV social anxiety disorder. Choy Y, Schneier FR, Heimberg RG, Oh K-S, Liebowitz MR, Depress Anxiety 2008 25 230 240 10.1002/da.20295 17340609
23. Cultural aspects in social anxiety and social anxiety disorder. Hofmann SG, Anu Asnaani MA, Hinton DE, Depress Anxiety 2010 27 1117 1127 10.1002/da.20759 21132847
24. Social anxiety disorder in the West and in the East. Stein DJ, Ann Clin Psychiatry 2009 21 109 117 19439161
25. Group cognitive behavior therapy for Japanese patients with social anxiety disorder: preliminary outcomes and their predictors. Chen J, Nakano Y, Ietzugu T, Ogawa S, Funayama T, Watanabe N, Noda Y, Furukawa TA, BMC Psychiatry 2007 7 69 10.1186/1471-244X-7-69 18067685
26. Video feedback with peer ratings in naturalistic anxiety-provoking situations for social anxiety disorder: preliminary report. Chen J, Furukawa TA, Nakano Y, Ietsugu T, Ogawa S, Funayama T, Watanabe N, Noda Y, Rapee RM, J Behav Ther Exp Psychiatry 2010 41 6 10 10.1016/j.jbtep.2009.08.005 19729149
27. Change in quality of life and their predictors in the long-term follow-up after group cognitive behavioral therapy for social anxiety disorder: a prospective cohort study. Watanabe N, Furukawa TA, Chen J, Kinoshita Y, Nakano Y, Ogawa S, Funayama T, Ietsugu T, Noda Y, BMC Psychiatry 2010 10 81 10.1186/1471-244X-10-81 20942980
28. Intensive group cognitive treatment and individual cognitive therapy vs. treatment as usual in social phobia: a randomized controlled trial. Mörtberg E, Clark DM, Sundin O, Aberg Wistedt A, Acta Psychiatr Scand 2007 115 142 154 10.1111/j.1600-0447.2006.00839.x 17244178
29. Cognitive therapy for social phobia: individual versus group treatment. Stangier U, Heidenreich T, Peitz M, Lauterbach W, Clark DM, Behav Res Ther 2003 41 991 1007 10.1016/S0005-7967(02)00176-6 12914803
30. Social phobia. Liebowitz MR, Mod Probl Pharmacopsychiatry 1987 22 141 173 2885745
31. Social anxiety disorder. Raj BA, Sheehan DV, Med Clin North Am 2001 85 711 733 10.1016/S0025-7125(05)70337-0 11349481
32. Factor structure of the Liebowitz Social Anxiety Scale in community-dwelling subjects in Japan. Sugawara N, Yasui-Furukori N, Kaneda A, Sato Y, Tsuchimine S, Fujii A, Danjo K, Takahashi I, Matsuzaka M, Kaneko S, Psychiatry Clin Neurosci 2012 66 525 528 10.1111/j.1440-1819.2012.02381.x 22988811
33. The autism-spectrum quotient (AQ): evidence from Asperger syndrome/high-functioning autism, males and females, scientists and mathematicians. Baron-Cohen S, Wheelwright S, Skinner R, Martin J, Clubley E, J Autism Dev Disord 2001 31 5 17 10.1023/A:1005653411471 11439754
34. First MB, Gibbon M, Users Guide for the Structured Clinical Interview for DSM-IV Axis I Disorders SCID-I: Clinician Version Washington: American Psychiatric Pub 1997 23505427
35. First MB, Gibbon M, Users Guide for the Structured Clinical Interview for DSM-IV Axis II Personality Disorders: SCID-II Washington: American Psychiatric Pub 1997 23505427
36. A cognitive model of social phobia. Clark DM, Wells A, Social Phobia: Diagnosis, Assessment, and Treatment New York: Guilford Press, Heimberg RG, Liebowitz M, Hope DA, Schneier FR, 1995 69 93
37. Cognitive therapy versus fluoxetine in generalized social phobia: a randomized placebo-controlled trial. Clark DM, Ehlers A, McManus F, Hackmann A, Fennell M, Campbell H, Flower T, Davenport C, Louis B, J Consult Clin Psychol 2003 71 1058 1067 14622081
38. Cognitive therapy versus exposure and applied relaxation in social phobia: a randomized controlled trial. Clark DM, Ehlers A, Hackmann A, McManus F, Fennell M, Grey N, Waddington L, Wild J, J Consult Clin Psychol 2006 74 568 578 16822113
39. Cognitive therapy vs interpersonal psychotherapy in social anxiety disorder: a randomized controlled trial. Stangier U, Schramm E, Heidenreich T, Berger M, Clark DM, Arch Gen Psychiatry 2011 68 692 700 10.1001/ archgenpsychiatry.2011.67 21727253
40. The Revised Cognitive Therapy Scale (CTS-R): psychometric properties. Blackburn I-M, James IA, Milne DL, Baker C, Standart S, Garland A, Reichelt FK, Behav Cogn Psychother 2001 29 431 446
41. Development and validation of measures of social phobia scrutiny fear and social interaction anxiety. Mattick RP, Clarke JC, Behav Res Ther 1998 36 455 470 10.1016/S0005-7967(97)10031-6 9670605
42. Measurement of social-evaluative anxiety. Watson D, Friend R, J Consult Clin Psychol 1969 33 448 457 5810590
43. Brief standard self-rating for phobic patients. Marks IM, Mathews AM, Behav Res Ther 1979 17 263 267 10.1016/0005-7967(79)90041-X 526242
44. Reliability and validity of the Japanese version of the Liebowitz Social Anxiety Scale. Asakura S, Inoue S, Sasaki F, Sasaki Y, Kitagawa N, Inoue T, Denda K, Ito M, Matsubara R, Koyama T, Seishin Igaku (Clinical Psychiatry) 2002 44 1077 1084
45. Development and validation of the Japanese version of Social Phobia Scale and Social Interaction Anxiety Scale. Kanai Y, Sasakawa S, Chen J, Suzuki S, Shimada H, Sakano Y, Shingshin-Igaku (Jpn J Psychosom Med) 2004 44 841 850
46. Standardization of Japanese version of FNE and SADS. Ishikawa R, Sasaki K, Fukui I, Koudou Ryouhou Kenkyu (Jap J Behav Ther) 1992 18 10 17
47. The selection and design of control conditions for randomized controlled trials of psychological interventions. Mohr DC, Spring B, Freedland KE, Beckner V, Arean P, Hollon SD, Ockene J, Kaplan R, Psychother Psychosom 2009 78 275 284 10.1159/000228248 19602916
48. What is the threshold for symptomatic response and remission for major depressive disorder, panic disorder, social anxiety disorder, and generalized anxiety disorder? Bandelow B, Baldwin DS, Dolberg OT, Andersen HF, Stein DJ, J Clin Psychiatry 2006 67 1428 1434 10.4088/JCP.v67n0914 17017830
49. Cohen J, Statistical Power Analysis in the Behavioral Sciences Hillsdale: Erlbaum 2 1988
50. The Liebowitz Social Anxiety Scale: a comparison of the psychometric properties of self-report and clinician-administered formats. Fresco DM, Coles ME, Heimberg RG, Liebowitz MR, Hami S, Stein MB, Goetz D, Psychol Med 2001 31 1025 1035 11513370
51. Impact of depression on treatment effectiveness and gains maintenance in social phobia: a naturalistic study of cognitive behavior group therapy. Marom S, Gilboa-Schechtman E, Aderka IM, Weizman A, Hermesh H, Depress Anxiety 2009 26 289 300 10.1002/da.20390 19170088
52. Predictors of response to cognitive-behavioral group therapy for social phobia. Chambless DL, Tran GQ, Glass CR, J Anxiety Disord 1997 11 221 240 10.1016/S0887-6185(97)00008-X 9220298
53. Pharmacological treatment of social anxiety disorder: a meta-analysis. Blanco C, Schneier FR, Schmidt A, Blanco-Jerez C-R, Marshall RD, Sánchez-Lacay A, Liebowitz MR, Depress Anxiety 2003 18 29 40 10.1002/da.10096 12900950
54. Optimizing treatment in social phobia: a review of treatment resistance. Van Ameringen M, Mancini C, Pipe B, Bennett M, CNS Spectr 2004 9 753 762 15448580
55. Social anxiety disorder. Stein MB, Stein DJ, Lancet 2008 371 1115 1125 10.1016/S0140-6736(08)60488-2 18374843